Voyager Therapeutics, Inc.（VYGR）内部人交易：高管与董事近期交易
过去 18 个月，共有 6 位内部人为 Voyager Therapeutics, Inc.（VYGR）报告了 19 笔 Form 4 交易（最近一笔 2026-04-03）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-03 | Sandrock Alfred | President and CEO | 卖出 | 11,511 | $44,548 |
| 2026-04-03 | Shiferman Gregory L. | SVP and General Counsel | 买入 | 50,000 | $0 |
| 2026-02-26 | Swartz Robin | COO & CBO | 卖出 | 6,458 | $24,347 |
| 2026-02-26 | Jorgensen Nathan D. | Chief Financial Officer | 卖出 | 4,668 | $17,598 |
| 2026-02-26 | Sandrock Alfred | President and CEO | 卖出 | 14,197 | $53,807 |
| 2026-02-26 | Carter Todd Alfred | Chief Scientific Officer | 卖出 | 4,174 | $15,694 |
| 2026-02-20 | Carter Todd Alfred | Chief Scientific Officer | 卖出 | 3,301 | $11,355 |
| 2026-02-20 | Sandrock Alfred | President and CEO | 卖出 | 11,732 | $40,006 |
| 2026-02-20 | Swartz Robin | COO & CBO | 卖出 | 3,882 | $13,354 |
| 2026-02-11 | Swartz Robin | COO & CBO | 卖出 | 4,569 | $17,591 |
| 2026-02-11 | Sandrock Alfred | President and CEO | 卖出 | 12,192 | $46,086 |
| 2026-02-11 | Carter Todd Alfred | Chief Scientific Officer | 卖出 | 3,525 | $13,571 |
| 2026-02-10 | Ferguson Toby | Chief Medical Officer | 买入 | 45,000 | $0 |
| 2026-02-10 | Carter Todd Alfred | Chief Scientific Officer | 买入 | 33,000 | $0 |
| 2026-02-10 | Swartz Robin | COO & CBO | 买入 | 45,000 | $0 |
| 2026-02-10 | Sandrock Alfred | President and CEO | 买入 | 86,250 | $0 |
| 2026-02-10 | Jorgensen Nathan D. | Chief Financial Officer | 买入 | 32,250 | $0 |
| 2025-10-07 | Jorgensen Nathan D. | Chief Financial Officer | 卖出 | 7,666 | $36,643 |
| 2025-08-20 | Ferguson Toby | Chief Medical Officer | 卖出 | 19,000 | $70,870 |
来源：SEC Form 4 申报文件 · 截至 2026-04-03